Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
Primary Purpose
Cervical Dystonia, Spasmodic Torticollis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
rTMS
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Dystonia focused on measuring cervical dystonia, torticollis, rTMS
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of idiopathic cervical dystonia
- Age 18 years or older
- Normal findings in the medical history, physical and neurological examination, except for dystonia
- Last treatment with botulinum toxin more than two months ago
Exclusion Criteria:
- History of seizure disorder
- Pregnancy- a pregnancy test will be performed for women of childbearing potential
- History of any other neurological disorders or conditions requiring the use of anti-depressants that are known to increase seizure threshold, neuroleptic medication, anticholinergic drugs and muscle relaxants
- History of neuroleptic medications/ prior use of neuroleptics
Sites / Locations
- University of New Mexico
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm Type
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Sham Comparator
Arm Label
Dorsal Premotor rTMS
Primary motor cortex rTMS
Supplemental Motor Area rTMS
Anterior Cingulate rTMS
Sham rTMS
Arm Description
0.2 Hz rTMS for 15 minutes
0.2 Hz rTMS for 15 minutes
0.2 Hz rTMS for 15 minutes
0.2 Hz rTMS for 15 minutes
0.2 Hz rTMS for 15 minutes
Outcomes
Primary Outcome Measures
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).
Secondary Outcome Measures
Dorsal Premotor-motor Inhibition (dPMI)
Composite Measure of Patient Rating of Symptoms and Tolerability
This measure will confirm the intervention tolerability by the patient. He/she scored the tolerability from 0-10, 0 being "completely tolerable" and 10 "completely intolerable."
Full Information
NCT ID
NCT01859247
First Posted
May 9, 2013
Last Updated
June 16, 2016
Sponsor
University of New Mexico
Collaborators
Dystonia Coalition, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), University Health Network, Toronto
1. Study Identification
Unique Protocol Identification Number
NCT01859247
Brief Title
Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
Official Title
Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2016
Overall Recruitment Status
Completed
Study Start Date
March 2013 (undefined)
Primary Completion Date
June 2014 (Actual)
Study Completion Date
June 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of New Mexico
Collaborators
Dystonia Coalition, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), University Health Network, Toronto
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The overall objective of this application is to therapeutically target the dysfunctional premotor-motor interaction in dystonia-and to provide a focused treatment of specific anatomical networks in order to reduce side effects and to improve symptom control over conventional therapies.
Detailed Description
We propose using repetitive transcranial magnetic stimulation (rTMS) over distinct premotor areas in patients with cervical dystonia (CD) with the goal of improving symptoms and reducing unwanted side effects. The knowledge gained in this proposed research will identify a specific premotor area to be targeted with rTMS that is expected to result in a novel intervention that could enhance or replace current treatments for CD. rTMS could be included as an adjunct treatment to botulinum toxin that could sustain treatment effect and decrease the frequency of re-injection, potentially resulting in cost savings without a decrease in symptom control. In addition to medical cost reduction, improved quality of life could be expected with the successful development of therapies that extend dystonia symptom control. rTMs has been FDA-approved for the treatment of depression and our proposal uses an even lower stimulation rate, suggesting continued use within clearly safe parameters. Successful completion of this research could lead to rapid adoption of this therapeutic modality.
We will test the hypothesis that rTMS of a distinct premotor site will provide more effective treatment of CD than non-specific activation of the entire premotor region. This will be done by performing a randomized, observer-blinded exploratory pilot study to determine the optimal site of rTMS over various sites of the premotor and motor cortex to improve the symptoms of cervical dystonia. Completion of this aim should lead to development of targeted TMS therapy for CD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Dystonia, Spasmodic Torticollis
Keywords
cervical dystonia, torticollis, rTMS
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
8 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Dorsal Premotor rTMS
Arm Type
Active Comparator
Arm Description
0.2 Hz rTMS for 15 minutes
Arm Title
Primary motor cortex rTMS
Arm Type
Active Comparator
Arm Description
0.2 Hz rTMS for 15 minutes
Arm Title
Supplemental Motor Area rTMS
Arm Type
Active Comparator
Arm Description
0.2 Hz rTMS for 15 minutes
Arm Title
Anterior Cingulate rTMS
Arm Type
Active Comparator
Arm Description
0.2 Hz rTMS for 15 minutes
Arm Title
Sham rTMS
Arm Type
Sham Comparator
Arm Description
0.2 Hz rTMS for 15 minutes
Intervention Type
Device
Intervention Name(s)
rTMS
Primary Outcome Measure Information:
Title
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)
Description
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).
Time Frame
Change from baseline pre-intervention TWSTRS score to post-intervention within 1 hour of treatment
Secondary Outcome Measure Information:
Title
Dorsal Premotor-motor Inhibition (dPMI)
Time Frame
Change from baseline dPMI to post-intervention within 1 hour of treatment
Title
Composite Measure of Patient Rating of Symptoms and Tolerability
Description
This measure will confirm the intervention tolerability by the patient. He/she scored the tolerability from 0-10, 0 being "completely tolerable" and 10 "completely intolerable."
Time Frame
Assessment completed immediately after rTMS treatment session
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of idiopathic cervical dystonia
Age 18 years or older
Normal findings in the medical history, physical and neurological examination, except for dystonia
Last treatment with botulinum toxin more than two months ago
Exclusion Criteria:
History of seizure disorder
Pregnancy- a pregnancy test will be performed for women of childbearing potential
History of any other neurological disorders or conditions requiring the use of anti-depressants that are known to increase seizure threshold, neuroleptic medication, anticholinergic drugs and muscle relaxants
History of neuroleptic medications/ prior use of neuroleptics
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sarah Pirio Richardson, MD
Organizational Affiliation
University of New Mexico
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
H.A. Jinnah, MD
Organizational Affiliation
Emory University
Official's Role
Study Director
Facility Information:
Facility Name
University of New Mexico
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
20633420
Citation
Beck S, Houdayer E, Richardson SP, Hallett M. The role of inhibition from the left dorsal premotor cortex in right-sided focal hand dystonia. Brain Stimul. 2009 Oct;2(4):208-14. doi: 10.1016/j.brs.2009.03.004. Epub 2009 May 3.
Results Reference
background
PubMed Identifier
18285800
Citation
Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nat Rev Neurosci. 2008 Mar;9(3):222-34. doi: 10.1038/nrn2337.
Results Reference
background
PubMed Identifier
15501683
Citation
Lefaucheur JP, Fenelon G, Menard-Lefaucheur I, Wendling S, Nguyen JP. Low-frequency repetitive TMS of premotor cortex can reduce painful axial spasms in generalized secondary dystonia: a pilot study of three patients. Neurophysiol Clin. 2004 Oct;34(3-4):141-5. doi: 10.1016/j.neucli.2004.07.003.
Results Reference
background
PubMed Identifier
15483042
Citation
Murase N, Rothwell JC, Kaji R, Urushihara R, Nakamura K, Murayama N, Igasaki T, Sakata-Igasaki M, Mima T, Ikeda A, Shibasaki H. Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain. 2005 Jan;128(Pt 1):104-15. doi: 10.1093/brain/awh315. Epub 2004 Oct 13.
Results Reference
background
PubMed Identifier
25923718
Citation
Pirio Richardson S, Tinaz S, Chen R. Repetitive transcranial magnetic stimulation in cervical dystonia: effect of site and repetition in a randomized pilot trial. PLoS One. 2015 Apr 29;10(4):e0124937. doi: 10.1371/journal.pone.0124937. eCollection 2015.
Results Reference
derived
Learn more about this trial
Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
We'll reach out to this number within 24 hrs